These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35315247)

  • 1. The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis.
    Lee ST; Lee HS; Lee WJ; Cha HA; Kim SH; Shin SY; Chu K; Lee SK
    Ann Clin Transl Neurol; 2022 May; 9(5):610-621. PubMed ID: 35315247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial.
    Hill M; Iro M; Sadarangani M; Absoud M; Cantrell L; Chong K; Clark C; Easton A; Gray V; Kneen R; Lim M; Liu X; Pike M; Solomon T; Vincent A; Willis L; Yu LM; Pollard AJ;
    BMJ Open; 2023 Nov; 13(11):e072134. PubMed ID: 37945292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin for the treatment of childhood encephalitis.
    Iro MA; Martin NG; Absoud M; Pollard AJ
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011367. PubMed ID: 28967695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ImmunoglobuliN in the Treatment of Encephalitis (IgNiTE): protocol for a multicentre randomised controlled trial.
    Iro MA; Sadarangani M; Absoud M; Chong WK; Clark CA; Easton A; Gray V; Kneen R; Lim M; Pike M; Solomon T; Vincent A; Willis L; Yu LM; Pollard AJ
    BMJ Open; 2016 Nov; 6(11):e012356. PubMed ID: 27810972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
    Li TR; Zhang YD; Wang Q; Shao XQ; Li ZM; Lv RJ
    BMC Neurosci; 2020 Mar; 21(1):13. PubMed ID: 32228575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of intravenous immunoglobulin versus intravenous methylprednisolone treatment in anti-N-methyl-d-aspartate receptor encephalitis.
    Gong X; Luo R; Liu J; Guo K; Li A; Liu X; Liu Y; Zhou D; Hong Z
    Eur J Neurol; 2022 Apr; 29(4):1117-1127. PubMed ID: 34918418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis.
    Jang Y; Lee ST; Kim TJ; Jun JS; Moon J; Jung KH; Park KI; Chu K; Lee SK
    Sci Rep; 2018 Jan; 8(1):1012. PubMed ID: 29343812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line immunotherapy of neuronal surface antibody-mediated autoimmune encephalitis: Assessment of therapeutic effectiveness and cost-efficiency.
    Cai MT; Lai QL; Zheng Y; Fang GL; Shen CH; Xu YF; Zhang YX; Ding MP
    Mult Scler Relat Disord; 2022 Oct; 66():104071. PubMed ID: 35917744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism.
    Connery K; Tippett M; Delhey LM; Rose S; Slattery JC; Kahler SG; Hahn J; Kruger U; Cunningham MW; Shimasaki C; Frye RE
    Transl Psychiatry; 2018 Aug; 8(1):148. PubMed ID: 30097568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Immunoglobulin Therapy in Refractory Autoimmune Dysautonomias: A Retrospective Analysis of 38 Patients.
    Schofield JR; Chemali KR
    Am J Ther; 2019; 26(5):570-582. PubMed ID: 29781817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generate-Boost: study protocol for a prospective, multicenter, randomized controlled, double-blinded phase II trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitis.
    Wickel J; Chung HY; Platzer S; Lehmann T; Prüss H; Leypoldt F; Günther A; Scherag A; Geis C;
    Trials; 2020 Jul; 21(1):625. PubMed ID: 32641101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
    Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
    Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Immunoglobulin as a Therapeutic Option for
    Daba M; Kang PB; Sladky J; Bidari SS; Lawrence RM; Ghosh S
    J Child Neurol; 2019 Oct; 34(11):687-691. PubMed ID: 31185782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Dose Steroids as First-Line Treatment Increased the Risk of In-Hospital Infections in Patients With Anti-NMDAR Encephalitis.
    Wang J; Lin J; Wang M; Meng Z; Zhou D; Li J
    Front Immunol; 2021; 12():774664. PubMed ID: 34975861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.
    Nosadini M; Eyre M; Molteni E; Thomas T; Irani SR; Dalmau J; Dale RC; Lim M; ; Anlar B; Armangue T; Benseler S; Cellucci T; Deiva K; Gallentine W; Gombolay G; Gorman MP; Hacohen Y; Jiang Y; Lim BC; Muscal E; Ndondo A; Neuteboom R; Rostásy K; Sakuma H; Sartori S; Sharma S; Tenembaum SN; Van Mater HA; Wells E; Wickstrom R; Yeshokumar AK
    JAMA Neurol; 2021 Nov; 78(11):1333-1344. PubMed ID: 34542573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of high-dose intravenous immunoglobulin in systemic autoimmune diseases.
    Tufan F; Kamali S; Erer B; Gul A; Inanc M; Ocal L; Konice M; Aral O
    Clin Rheumatol; 2007 Nov; 26(11):1913-5. PubMed ID: 17636363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
    Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
    Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tamame T; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H; Miura M;
    Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort.
    Lee WJ; Lee ST; Byun JI; Sunwoo JS; Kim TJ; Lim JA; Moon J; Lee HS; Shin YW; Lee KJ; Kim S; Jung KH; Jung KY; Chu K; Lee SK
    Neurology; 2016 May; 86(18):1683-91. PubMed ID: 27037228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with immunoadsorption therapy in four patients with severe and refractory anti-N-methyl-D-aspartate receptor encephalitis.
    Yang Y; Zhang B; Li M; Li J
    J Clin Apher; 2021 Dec; 36(6):886-892. PubMed ID: 34520046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.